carisoprodol | apollo | +9191 46 950 950 · and resume your usual dosing schedule. do not double...
TRANSCRIPT
Carisoprodol | APOLLO | +9191 46 950 950
Carisoprodol | APOLLO | +9191 46 950 950
Carisoprodol
CAS Number : 78-44-4
Protein binding : 60%
Molecular Weight : 260.33 g/mol Molecular Formula : C12H24N2O4
Systematic (IUPAC) : 2-methyl-2-({[(propan-2-yl)carbamoyl]oxy}methyl)pentyl carbamate
DRUG DESCRIPTION
carisoprodol CAS No 78-44-4
Carisoprodol is a muscle relaxer that works by blocking pain sensations between the nerves and the brain. Carisoprodol is used together with rest and physical
therapy to treat injuries and other painful musculoskeletal conditions.
Carisoprodol may also be used for other purposes not listed in this medication guide.
This medication may be habit-forming and should be used only by the person it was prescribed for.
Carisoprodol should never be given to another person, especially someone who has a history of drug abuse or addiction. Keep the medication in a secure place where
others cannot get to it. You may have withdrawal symptoms when you stop using carisoprodol after using it over a long period of time. Do not stop using this
medication suddenly without first talking to your doctor. You may need to use less and less before you stop the medication completely. Carisoprodol can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase drowsiness and dizziness caused by
carisoprodol.
DOSAGE
carisoprodol CAS No 78-44-4
Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the
directions on your prescription label. Take each dose with a full glass of water. Store
carisoprodol at room temperature away from moisture and heat. Take the missed dose of carisoprodol as soon
as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra carisoprodol to make up the missed dose.Seek emergency medical
attention if you think you have used too much carisoprodol.
Overdose symptoms may include shallow breathing, vision problems, fast heartbeat, confusion,
hallucinations (seeing things), muscle stiffness, feeling light-headed, fainting, or seizure (convulsions).
SIDE EFFECTS
carisoprodol CAS No 78-44-4
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using carisoprodol and call your doctor at once if you have any
of these serious side effects:
*paralysis (loss of feeling);
*extreme weakness or lack of coordination;
*feeling light-headed, fainting;
*fast heartbeat;
*seizure (convulsions);
*vision loss; or
*agitation, confusion. Less serious side effects may include:
*drowsiness, dizziness, tremor;
*headache;
*depression, feeling irritable;
*blurred vision;
*sleep problems (insomnia); or
*nausea, vomiting, hiccups, upset stomach.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome
side effect.
PRECAUTIONS
carisoprodol CAS No 78-44-4
Before taking carisoprodol, tell your doctor or pharmacist if you are allergic to it; or to meprobamate, tybamate, or mebutamate; or if you have any other allergies. Also tell your doctor if you have ever had an
unusual reaction to carisoprodol or any of the medications listed above.
This medication should not be used if you have a certain medical condition. Before using this medication, tell your doctor if you have: acute intermittent porphyria.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney
problems, liver problems, history of regular alcohol/drug abuse, asthma, seizure disorder.
To reduce dizziness and lightheadedness, get up slowly when rising from a seated or lying position.
This drug may make you dizzy or drowsy; use caution engaging in activities requiring alertness such as driving,
swimming or using machinery. Avoid alcoholic beverages.
This medication is not recommended for use during pregnancy. It may rarely harm an unborn baby. Consult your doctor for more details and to discuss reliable forms of birth control. If you become pregnant while taking this medication, tell your doctor immediately. This medication passes into breast milk and may have undesirable effects on a nursing infant. Consult your
doctor before breast-feeding.
PATIANT INFORMATION
carisoprodol CAS No 78-44-4
may cause drowsiness and/or dizziness, patients should be advised to assess their individual responsebefore engaging in potentially hazardous activities such as driving a motor vehicle or operating machinery
Avoidance of Alcohol and Other CNS Depressants
Patients should be advised to avoid alcoholic beverages
and and to check with their doctor before taking other CNS depressants such as benzodiazepines, opioids, tricyclic antidepressants, sedating antihistamines, or
other sedativesPatients should be advised that treatmentshould be limited to acute use (up to two or three weeks) for the relief of acute, musculoskeletal discomfort. If symptoms still persist, patients should
contact their healthcare provider for further evaluation.
CONSUMER INFORMATION
carisoprodol CAS No 78-44-4
Take this medication by mouth with or without food, usually 4 times a day or as directed by your doctor.
Dosage is based on your medical condition and response to treatment. Your doctor will usually direct you to take this medication for your current injury only. Do not save this drug for future use. Follow your doctor's directions on when to reduce your dose, take it less often, or stop
taking it. This medication may cause dependence, especially if it has been used regularly for an extended time or if it has been used in high doses. In such cases, withdrawal reactions (e.g., stomach cramps, trouble sleeping,
headache, nausea) may occur if you suddenly stop this drug. To prevent withdrawal when stopping
extended/regular treatment with this drug, gradually reduce the dosage as directed. Consult your doctor or pharmacist for more details, and report any withdrawal
reactions immediately. Though it is very unlikely to occur, this medication can
also result in abnormal drug-seeking behavior (addiction/habit-forming). Do not increase your dose, take it more frequently or use it for a longer time than prescribed. Properly stop the medication when so directed. This will lessen the chances of becoming
addicted. Tell your doctor if your symptoms persist or worsen
after 2 to 3 weeks. Your healthcare professionals (e.g., doctor or
pharmacist) may already be aware of any possible drug interactions and may be monitoring you for it. Do not start, stop or change the dosage of any medicine before
checking with them first. Before using this medication, tell your doctor or
pharmacist of all prescription and nonprescription/herbal products you may use, especially
of: melatonin, other muscle relaxants (e.g., cyclobenzaprine, methocarbamol).
Tell your doctor or pharmacist if you also take drugs that cause drowsiness such as: certain antihistamines (e.g., diphenhydramine), anti-anxiety drugs (e.g., diazepam), anti-seizure drugs (e.g., carbamazepine), medicine for
sleep (e.g., zolpidem, temazepam), narcotic pain relievers (e.g., codeine), psychiatric medications (e.g.,
phenothiazines such as chlorpromazine or tricyclics such as amitriptyline), tranquilizers. Alcoholic beverages will
also increase the drowsiness effect. If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose
and resume your usual dosing schedule. Do not double the dose to catch up.
Store in a tightly closed container at room temperature between 59-86 degrees F (15-30 degrees C) away from moisture and sunlight. Do not store in the bathroom. Keep all medicines away from children and pets.
Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal
company for more details about how to safely discard your product.
Type
small molecule
Description
A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an
adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful
muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
Synonyms
Carisoprodate
Carisoprodatum
Isomeprobamate
Isoprotane
Isoprothane
Taxonomy
Kingdom Organic
Classes
Carbamates and Derivatives
Substructures
Carbamates and Derivatives
Ethers
Pharmacology
Indication
For the relief of discomfort associated with acute, painful, musculoskeletal conditions.
Pharmacodynamics
Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an
anxiolytic agent.
Mechanism of Action
Carisoprodol is a central nervous system depressant that acts as a sedative and skeletal muscle relaxant. Rather than acting directly on skeletal muscle, carisoprodol
interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. Its exact mechanism of
action is not yet known.
Metabolism
Hepatic. Metabolized in the liver via the cytochrome P450 oxidase isozyme CYP2C19.
Route of Elimination
Carisoprodol is eliminated by both renal and non-renal routes.
Toxicity
Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include
dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension.
Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema
multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such
additives
apollo | asia Division
apollo Pharmaceuticals INDIA [P] Ltd|asia Division
Mr.Vipin Saxena|CEO
DIRECT:+912265785588
Wireline Purchase HELPDESK:
+91-22-65050001
+91-22-65650001
Wireline Sales HELPDESK:
+91-22-65500009
+91-22-65050009
Wireless 24x7 HELPDESK:
+9191-46-951951
+9191-46-950950
Blackberry Pin :
32E6500D | 32E65010 | 28415C58
Email:
www.apollo.mn
www.apollo.com.co
www.apollopharmaceuticals.com
Chat: MSN Hotmail:VipinrSaxena
Skype NAME:VipinrSaxena
Rocketmail:VipinrSaxena
Google mail:VipinrSaxena
BlackBerry:28415C58
Regd. Office :-
1104, Maker Chamber V, Nariman Point
Mumbai, INDIA
Pin:400021
Industrial Office
D-62, OIC India
Oshiwara Industrial Centre, New Link Road, Goregoan West, Mumbai, INDIA
Pin:400104
Manufacturing Unit Address:
Plot No. 117A, Village: Chamble
Near MonaTona Limited.Wada, Maharashtra,
PIN : 421312 | INDIA
Email:
www.apollo.mn | www.apollo.com.co | www.apollopharmaceuticals.Com
